XML 39 R27.htm IDEA: XBRL DOCUMENT v3.20.4
SHAREHOLDERS’ EQUITY (Tables)
3 Months Ended
Nov. 30, 2020
Equity [Abstract]  
Schedule of dividends declared and paid
                  
(in thousands, except dividend per share amounts) Fiscal Year 2021
Record Date  Distribution Date  Number of Shares
Outstanding on
Record Date
   Dividend per
Share
   Total
Amount
 
10/26/2020  11/02/2020   19,924   $0.06   $1,195 
Total               $1,195 

 

(in thousands, except dividend per share amounts) Fiscal Year 2020
Record Date  Distribution Date  Number of Shares
Outstanding on
Record Date
   Dividend per
Share
   Total
Amount
 
10/25/2019  11/01/2019   17,606   $0.06   $1,056 
1/27/2020  2/03/2020   17,646   $0.06    1,059 
4/24/2020  5/01/2020   17,769   $0.06    1,066 
7/27/2020  8/03/2020   17,820   $0.06    1,069 
Total               $4,250 
Schedule of stock option activity
               
(in thousands, except per share and weighted-average amounts)  Number of   Weighted-
Average
Exercise
Price
   Weighted-
Average
Remaining
Contractual
 
Transactions during the three months ended November 30, 2020  Options   Per Share   Life 
Outstanding, August 31, 2020   1,224   $17.76    6.79 
Granted   26   $59.91      
Exercised   (34)  $14.04      
Cancelled/Forfeited   (11)  $24.18      
Outstanding, November 30, 2020   1,205   $18.73    6.62 
Exercisable, November 30, 2020   583   $11.16    5.35 
Schedule of fair value of options
          
(in thousands except pricing)  Three months ended, November 30 2020   Fiscal Year 2020 
Estimated fair value of awards granted  $560   $2,997 
Unvested forfeiture rate   0%    0% 
Weighted average grant price  $59.91   $39.23 
Weighted average market price  $59.91   $39.23 
Weighted average volatility   36.35%    33.56% 
Weighted average risk-free rate   0.47%    1.39% 
Weighted average dividend yield   0.40%    0.65% 
Weighted average expected life   6.65 years    6.67 years 
Schedule of options by exercise price range
                                   
(in thousands except prices)         
Exercise Price   Awards Outstanding   Awards Exercisable 
Low   High   Quantity   Weighted
Average
Remaining
Contractual
Life
  Weighted
Average
Exercise
Price
   Quantity   Weighted
Average
Remaining
Contractual
Life
   Weighted
Average
Exercise
Price
 
$6.75   $8.00    169   3.77 years  $6.85    169    3.77 years   $6.85 
$8.01   $16.00    535   5.80 years  $9.99    337    5.74 years   $9.99 
$16.01   $24.00    208   7.51 years  $20.42    49    6.19 years   $20.61 
$24.01   $38.00    204   8.90 years  $33.46    28    8.70 years   $34.83 
$38.01   $52.00    20   9.31 years  $38.64           $ 
$52.01   $61.84    69   9.68 years  $61.10           $ 
           1,205   6.62 years  $18.73    583    5.35 years   $11.16 

 

During the three months ended November 30, 2020 the company issued 1,275 shares of stock to nonmanagement directors of the Company valued at $83 thousand as compensation for services rendered to the Company.

 

In August 2020, the company closed an underwritten public offering of 2,090,909 shares of its common stock to the public at $55.00 per share, which included the full exercise of the underwriters’ option to purchase 272,727 additional shares of common stock. The aggregate gross proceeds to the company from this offering were approximately $115 million, before deducting underwriting discounts and commissions; net proceeds were approximately $107.7 million. The offering was made pursuant to the Company’s automatic shelf registration statement on Form S-3 filed with the SEC on July 9, 2020.

 

The balance of par value common stock and additional paid in capital as of November 30, 2020 was $10 thousand and $129.2 million, respectively.